Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in PRLD — Prelude Therapeutics Inc

CIK 1390777 NEW YORK, NY
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$363,436
+$341,462 QoQ
Shares Held
68,187
+138.3% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 75 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. PRLD ranks #266 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in PRLD

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $363,436 68,187
2025-03-31 $21,974 28,613
2024-12-31 $36,480 28,613
2024-09-30 $59,228 28,613
2024-06-30 $138,211 36,276
2024-03-31 $189,922 40,068
2023-12-31 $216,061 50,600
2023-09-30 $101,604 32,882
2023-06-30 $138,672 30,816
2022-12-31 $174,429 28,879
2022-09-30 $192,872 29,179
2022-06-30 $152,366 29,189
2022-03-31 $412,757 59,820
2021-12-31 $718,065 57,676
2021-09-30 $1,072,249 34,312
2021-06-30 $866,171 30,254
2021-03-31 $1,344,788 31,036
2020-12-31 $2,216,117 30,973